Promoter and neck region length variation of DC-SIGN is not associated with susceptibility to tuberculosis in Tunisian patients

Human Immunology

Volumn 68, Issue 11, 2007, Pages 908-912

  Ben Ali, Meriem ^a   Barreiro, Luis B ^b   Chabbou, Abdellatif ^c   Haltiti, Raja ^d   Braham, Ezzeddine ^e   Neyrolles, Olivier ^b   Dellagi, Koussay ^a   Gicquel, Brigitte ^b   Quintana Murci, Lluis ^b   Barbouche, Mohamed Ridha ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b INSTITUT PASTEUR   (France)

^c ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^d Service de Pneumo allergologie Hôpital de Menzel Bourguiba   (Tunisia)

^e Direction régionale de la santé publique de Bizerte ^*  (Tunisia)

Author keywords

DC SIGN; Neck region; Promoter region; Susceptibility; Tuberculosis

Indexed keywords

CD209 ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE SEQUENCE; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUBERCULOSIS; TUNISIA;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; DENDRITIC CELLS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LECTINS, C-TYPE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RECEPTORS, CELL SURFACE; TUBERCULOSIS; TUNISIA;

EID: 37049037527     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.09.003     Document Type: Article

References (19)

1. Murray C.J., Styblo K., and Rouillon A. Tuberculosis in developing countries: Burden, intervention and cost. Bull Int Union Tuberc Lung Dis 65 (1990) 6
2. Bellamy R. Susceptibility to mycobacterial infections: The importance of host genetics. Genes Immun 4 (2003) 4
3. Casanova J.L., and Abel L. Genetic dissection of immunity to mycobacteria: The human model. Annu Rev Immunol 20 (2002) 581
4. Kimbrell D.A., and Beutler B. The evolution and genetics of innate immunity. Nat Rev Genet 2 (2001) 256
5. Quesniaux V., Fremond C., Jacobs M., Parida S., Nicolle D., and Ryffel B. Toll-like receptor pathways in the immune responses to mycobacteria. Microbes Infect 6 (2004) 946
6. Tailleux L., Schwartz O., Herrmann J.L., Pivert E., Jackson M., and Neyrolles O. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 197 (2003) 121
7. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., and van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000) 587
8. Geijtenbeek T.B., Krooshoop D.J., Bleijs D.A., van Vliet S.J., van Duijnhoven G.C., and van Kooyk Y. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 1 (2000) 353
9. Geijtenbeek T.B., van Vliet S.J., Engering A., 't Hart B.A., and van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 22 (2004) 33
10. Gramberg T., Zhu T., Chaipan C., Marzi A., Liu H., and Pohlmann S. Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens. Virology 347 (2006) 354
11. Geijtenbeek T.B., Van Vliet S.J., Koppel E.A., Sanchez-Hernandez M., Vandenbroucke-Grauls C.M., and Van Kooyk Y. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197 (2003) 7
12. Tailleux L., Maeda N., Nigou J., Gicquel B., and Neyrolles O. How is the phagocyte lectin keyboard played?. Master class lesson by Mycobacterium tuberculosis. Trends Microbiol 11 (2003) 259
13. Sakuntabhai A., Turbpaiboon C., Casademont I., Chuansumrit A., and Julier C. A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 37 (2005) 507
14. Martin M.P., Lederman M.M., Hutcheson H.B., Goedert J.J., and Carrington M. Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection. J Virol 78 (2004) 14053
15. Barreiro L.B., Neyrolles O., Babb C.L., Tailleux L., Quach H., and Quintana-Murci L. Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med 3 (2006) e20
16. Gómez L.M., Anaya J.M., Sierra-Filardi E., Cadena J., Corbí A., and Martín J. Analysis of DC-SIGN (CD209) functional variants in patients with tuberculosis. Hum Immunol 67 (2006) 808
17. Barreiro L.B., Neyrolles O., Babb C.L., van Helden P.D., Gicquel B., and Quintana-Murci L. Length variation of DC-SIGN and L-SIGN neck region has no impact on tuberculosis susceptibility. Hum Immunol 68 (2007) 106
18. Feinberg H., Guo Y., Mitchell D.A., Drickamer K., and Weis W.I. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 280 (2005) 132
19. Liu H., Hladik F., Andrus T., Sakchalathorn P., Lentz G.M., and Zhu T. Most DC-SIGNR transcripts at mucosal HIV transmission sites are alternatively spliced isoforms. Eur J Hum Genet 13 (2005) 707